Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- NEW PRODUCTS
December 20, 2004
- Dainippon to Beef Up Sales of Prorenal
December 20, 2004
- New Company to Focus on OB/GYN, ENT, CV Areas: Teikoku Hormone, Grelan
December 20, 2004
- BUSINESS NEWS IN BRIEF -2-
December 20, 2004
- WEBSITE NEWS
December 20, 2004
- NEW PRODUCTS
December 20, 2004
- Eliminate Provisional Delivery, Clarify Allowance Payment Criteria: Ryukaikon
December 20, 2004
- Committee Calls For Patents on Combinations of Drugs, New Administration Methods
December 20, 2004
- REGULATORY NEWS IN BRIEF
December 20, 2004
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
December 20, 2004
- AstraZeneca to Boost Its Market Share to 4.3-4.5% by 2010: New President Kato
December 20, 2004
- PRESS SEMINAR
December 20, 2004
- MONITOR
December 20, 2004
- Most Widely Used Generics Are from Research-oriented Companies: JSGM Survey
December 20, 2004
- Dainippon, Sumitomo "Need to Consider Further M&A": Datamonitor
December 20, 2004
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
December 20, 2004
- ABeam Consulting Lists 5 Factors for Successful M&As
December 20, 2004
- Sanjiu Honsoudou Medical & Pharm. to Create Drug Wholesaler in China
December 20, 2004
- Eisai to Strengthen Business Infrastructure in China, India
December 20, 2004
- MEDICAL DEVICE NEWS IN BRIEF
December 20, 2004
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…